1.
Duloxetine: a review of its pharmacology and use in chronic pain management
by Bellingham, Geoff A
Regional anesthesia and pain medicine, 2010-05, Vol.35 (3), p.294-303
2.
Dissociable effects of monoamine reuptake inhibitors on distinct forms of impulsive behavior in rats
by Baarendse, P.J.J
Psychopharmacology, 2012, Vol.219 (2), p.313-326
3.
Roles of arbuscular mycorrhizas in plant nutrition and growth: new paradigms from cellular to ecosystem scales
by Smith, Sally E
Annual review of plant biology, 2011, Vol.62 (1), p.227-250
4.
Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-c...
by Anthenelli, Robert M, Prof
The Lancet (British edition), 2016, Vol.387 (10037), p.2507-2520
5.
Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals
by Crawford, Andrew A
Psychopharmacology, 2014-02-13, Vol.231 (15), p.2921-2931
6.
Augmentation effect of combination therapy of aripiprazole and antidepressants on forced swimming test in mice
by Bourin, Michel
Psychopharmacologia, 2009-06-11, Vol.206 (1), p.97-107
7.
Trazodone Improves Sleep Parameters in Alzheimer Disease Patients: A Randomized, Double-Blind, and Placebo-Controlled Study
by Camargos, Einstein F., Ph.D
The American journal of geriatric psychiatry, 2014, Vol.22 (12), p.1565-1574
8.
An efficient three-dimensional rhizosphere modeling capability to study the effect of root system architecture on soil water and reactive transport
by Fang, Yilin
Plant and soil, 2019-06-21, Vol.441 (1-2), p.33-48
9.
Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: A review
by Tuccori, Marco, PharmD
Clinical therapeutics, 2009, Vol.31, p.1426-1453
10.
Comparative efficacy of pharmacological and non-pharmacological interventions in fibromyalgia syndrome: network meta-analysis
by Nüesch, Eveline
Annals of the rheumatic diseases, 2013-06, Vol.72 (6), p.955-962
11.
Effects of MDMA alone and after pretreatment with reboxetine, duloxetine, clonidine, carvedilol, and doxazosin on pupillary light reflex
by Hysek, Cédric M
Psychopharmacologia, 2012-06-15, Vol.224 (3), p.363-376
12.
Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data
by Whittington, Craig J
The Lancet (British edition), 2004, Vol.363 (9418), p.1341-1345
13.
Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: An update
by Spina, Edoardo, MD
Clinical therapeutics, 2008, Vol.30 (7), p.1206-1227
14.
Fluoxetine regulates the expression of neurotrophic/growth factors and glucose metabolism in astrocytes
by Allaman, Igor
Psychopharmacologia, 2011-02-08, Vol.216 (1), p.75-84
15.
Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development
by Casper, Regina C
Psychopharmacologia, 2011-04-16, Vol.217 (2), p.211-219
16.
Infant developmental outcomes following prenatal exposure to antidepressants, and maternal depressed mood and positive affect
by Hanley, Gillian E
Early human development, 2013, Vol.89 (8), p.519-524
17.
In Utero Exposure to Selective Serotonin Reuptake Inhibitors and Risk for Autism Spectrum Disorder
by Gidaya, Nicole B
Journal of autism and developmental disorders, 2014-05-07, Vol.44 (10), p.2558-2567
18.
Molecular basis of atypicality of bupropion inferred from its receptor engagement in nervous system tissues
by Kim, Eric J
Psychopharmacology, 2018-07-01, Vol.235 (9), p.2643-2650
19.
Antidepressant Specificity of Serotonin Transporter Suggested by Three LeuT-SSRI Structures
by Zhou, Z
Nature structural biology, 2009-01-01, Vol.16
20.
Mitochondrial calcium uptake in organ physiology: from molecular mechanism to animal models
by Mammucari, Cristina
Pflügers Archiv, 2018-03-15, Vol.470 (8), p.1165-1179
